JP2022547080A5 - - Google Patents
Info
- Publication number
- JP2022547080A5 JP2022547080A5 JP2022514679A JP2022514679A JP2022547080A5 JP 2022547080 A5 JP2022547080 A5 JP 2022547080A5 JP 2022514679 A JP2022514679 A JP 2022514679A JP 2022514679 A JP2022514679 A JP 2022514679A JP 2022547080 A5 JP2022547080 A5 JP 2022547080A5
- Authority
- JP
- Japan
- Prior art keywords
- epithelial cells
- pharmaceutical composition
- composition according
- allergic
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025111395A JP2025143368A (ja) | 2019-09-04 | 2025-07-01 | 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962895737P | 2019-09-04 | 2019-09-04 | |
| US62/895,737 | 2019-09-04 | ||
| US201962923770P | 2019-10-21 | 2019-10-21 | |
| US62/923,770 | 2019-10-21 | ||
| US201962924359P | 2019-10-22 | 2019-10-22 | |
| US62/924,359 | 2019-10-22 | ||
| US202062964995P | 2020-01-23 | 2020-01-23 | |
| US62/964,995 | 2020-01-23 | ||
| PCT/US2020/049541 WO2021046448A1 (en) | 2019-09-04 | 2020-09-04 | Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025111395A Division JP2025143368A (ja) | 2019-09-04 | 2025-07-01 | 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022547080A JP2022547080A (ja) | 2022-11-10 |
| JP2022547080A5 true JP2022547080A5 (enExample) | 2024-04-02 |
Family
ID=74853054
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514679A Pending JP2022547080A (ja) | 2019-09-04 | 2020-09-04 | 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 |
| JP2025111395A Pending JP2025143368A (ja) | 2019-09-04 | 2025-07-01 | 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025111395A Pending JP2025143368A (ja) | 2019-09-04 | 2025-07-01 | 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220339134A1 (enExample) |
| EP (1) | EP4025201A4 (enExample) |
| JP (2) | JP2022547080A (enExample) |
| CN (1) | CN114650814A (enExample) |
| AU (1) | AU2020343029A1 (enExample) |
| BR (1) | BR112022003985A2 (enExample) |
| CA (1) | CA3153088A1 (enExample) |
| MX (1) | MX2022002687A (enExample) |
| WO (1) | WO2021046448A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022056311A1 (en) * | 2020-09-10 | 2022-03-17 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use |
| CN118524834A (zh) * | 2021-12-03 | 2024-08-20 | 株式会社日水 | 氧化应激缓和方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010037180A1 (en) * | 2008-10-03 | 2010-04-08 | Glycan Biosciences Pty Ltd | Anionic oligosaccharide conjugates |
| US20130190399A1 (en) * | 2009-10-31 | 2013-07-25 | Martek Biosciences Corporation | Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA) |
| WO2016130522A1 (en) * | 2015-02-09 | 2016-08-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases |
| US20170014365A1 (en) * | 2015-07-14 | 2017-01-19 | The Board Of Regents Of The University Of Oklahoma | Compositions Containing Very Long Chain Saturated Fatty Acids and Methods of Use |
| WO2017077528A2 (en) * | 2015-11-02 | 2017-05-11 | Salzman Lovelace Investments, Ltd. | Methods and pharmaceutical compositions for treatment of lung inflammation |
| CA3056882A1 (en) * | 2017-03-20 | 2018-09-27 | University Of Southern California | Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use |
| US20220226270A1 (en) * | 2019-04-04 | 2022-07-21 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use |
-
2020
- 2020-09-04 WO PCT/US2020/049541 patent/WO2021046448A1/en not_active Ceased
- 2020-09-04 AU AU2020343029A patent/AU2020343029A1/en not_active Abandoned
- 2020-09-04 JP JP2022514679A patent/JP2022547080A/ja active Pending
- 2020-09-04 BR BR112022003985A patent/BR112022003985A2/pt unknown
- 2020-09-04 US US17/639,757 patent/US20220339134A1/en active Pending
- 2020-09-04 MX MX2022002687A patent/MX2022002687A/es unknown
- 2020-09-04 CN CN202080072552.7A patent/CN114650814A/zh active Pending
- 2020-09-04 CA CA3153088A patent/CA3153088A1/en active Pending
- 2020-09-04 EP EP20860080.9A patent/EP4025201A4/en not_active Withdrawn
-
2025
- 2025-07-01 JP JP2025111395A patent/JP2025143368A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ranjbar et al. | Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table | |
| JP7169693B2 (ja) | 呼吸器疾患の治療 | |
| Sampson | The role of eosinophils and neutrophils in inflammation | |
| JP2009510044A5 (enExample) | ||
| JP2017528507A5 (enExample) | ||
| JP2007533687A5 (enExample) | ||
| HRP20171044T1 (hr) | Kemijski i metabolički stabilni dipeptid s potentnom aktivnošću blokatora natrijevog kanala | |
| JP2023518974A (ja) | コロナウイルス感染症による化学感覚機能障害の治療 | |
| JP2022527401A5 (enExample) | ||
| JP2022520990A (ja) | 呼吸器疾患の治療の方法 | |
| JP2024511141A (ja) | オリスミラストによる化膿性汗腺炎の治療 | |
| JP2026041886A5 (enExample) | ||
| JP2016525573A5 (enExample) | ||
| WO2021213287A1 (zh) | Irak4抑制剂治疗ali/ards中的应用 | |
| JP2021530440A5 (enExample) | ||
| JP2021522255A5 (enExample) | ||
| JP5753843B2 (ja) | ｐ４０依存性疾患の治療におけるベンジダミンの使用 | |
| JP2008533079A5 (enExample) | ||
| JP2026510948A (ja) | 慢性閉塞性肺疾患患者におけるエンテロウイルスの治療方法 | |
| JP7539485B2 (ja) | ピラゾール誘導体の肺線維症治療剤 | |
| US20190151283A1 (en) | NON-STEROIDAL SELECTIVE GLUCOCORTICOID RECEPTOR AGONISTIC MODULATORS (SEGRAMs) AND USES THEREOF | |
| US20210177798A1 (en) | NON-STEROIDAL SELECTIVE GLUCOCORTICOID RECEPTOR AGONISTIC MODULATORS (SEGRAMs) AND USES THEREOF | |
| JP2021516693A (ja) | 乾性眼の予防または治療のための組成物 | |
| CN113412261A (zh) | 苯并咪唑化合物、其制备方法及其用途 | |
| CN1997367B (zh) | 预防和治疗过敏性炎症的组合物 |